A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors
Abstract Delta-like protein 3 (DLL3) is highly expressed in solid tumors, including neuroendocrine carcinomas/neuroendocrine tumors (NEC/NET). Rovalpituzumab tesirine (Rova-T) is a DLL3-targeting antibody-drug conjugate. Patients with NECs and other advanced DLL3-expressing tumors were enrolled in t...
Guardado en:
Autores principales: | Aaron S. Mansfield, David S. Hong, Christine L. Hann, Anna F. Farago, Himisha Beltran, Saiama N. Waqar, Andrew E. Hendifar, Lowell B. Anthony, Matthew H. Taylor, Alan H. Bryce, Scott T. Tagawa, Karl Lewis, Jiaxin Niu, Christine H. Chung, James M. Cleary, Michael Rossi, Carrianne Ludwig, Ricardo Valenzuela, Yan Luo, Rahul Aggarwal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/41cea5032a0d44ac9ceef9a9bed44b7a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2
por: Yuko Sakai-Tagawa, et al.
Publicado: (2021) - Phi Delta Kappan
-
A Tale of Two Deltas: Dam-Induced Hydro-Morphological Evolution of the Volta River Delta (Ghana) and Yellow River Delta (China)
por: Dongxue Li, et al.
Publicado: (2021) -
Recovery and Restoration of Biloxi Marsh in the Mississippi River Delta
por: G. Paul Kemp, et al.
Publicado: (2021) -
A REVIEW OF WETLANDS AND COASTAL RESOURCES OF THE NIGER DELTA: POTENTIALS, CHALLENGES AND PROSPECTS
por: Nwankwoal, H. O., et al.
Publicado: (2021)